Altered protein glycosylation compared with the disease-free state is a universal feature of
cancer cells. It has long been established that distinct glycan structures are associated with …

The majority of cell differentiation associated tumor markers reported to date are either
glycoproteins or glycolipids. Despite there being a large number of glycoproteins reported …

Detection of cancer at early stages that can be treated through surgery is a difficult task. One
methodology for cancer biomarker discovery exploits the fact that glycoproteins produced by …

Alteration of glycosylation, a hallmark of cancer, results in the production of tumor-
associated glycans or glycoproteins. These molecules are subsequently secreted or …

Despite significant worldwide investment in research, cancer remains one of the most
common cause of death in the world. Early detection and reliable diagnosis are the keys to …

Abstract Changes in glycosylation of glycoproteins and glycolipids is a common feature of
cancer and may influence cancer cell behaviour, perhaps by enabling cell‐cell interactions …

Protein glycosylation is one of the most common posttranslational modifications in
mammalian cells. It is involved in many biological pathways and molecular functions and is …

It has been suggested that the diversity of glycosylation structures that form during cancer
progression and the sensitivity with which they are able to be detected have great potential …

Aberrant glycosylation is frequently found in cancer, and efforts for biomarker discovery
include the preparation of aberrant glycoproteins as promising analytes. Several lectins that …

The significance of glycomic profiling has been highlighted by recent findings that structural
changes of glycans are observed in many diseases, including cancer. Therefore, glycomic …